Biocept

$4.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-1.52%) Today
-$0.07 (-1.55%) As of 5:14 PM EST after-hours

Why Robinhood?

You can buy or sell Biocept and other stocks, options, and ETFs commission-free!

About BIOC

Biocept, Inc. Common Stock, also called Biocept, is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA. The listed name for BIOC is Biocept, Inc. Common Stock.

CEO
Michael W. Nall
Employees
88
Headquarters
San Diego, California
Founded
1997
Market Cap
60.69M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.01M
High Today
$4.61
Low Today
$4.41
Open Price
$4.61
Volume
307.84K
52 Week High
$13.00
52 Week Low
$2.11

Collections

BIOC Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Available Nov 12, After Hours

You May Also Like